Federal Register Notice: FDA’s Arthritis Advisory Committee will meet 7/29, from 8:30 a.m. to 3:30 p.m. at the Hilton Washington DC/Silver Spring, The Ballrooms, 8727 Colesville Rd., Silver Spring, MD. Contact Nicole Vesely, (301) 827-6793. The committee will discuss Hoffmann-La Roche, Inc.’s BLA for Actemra (tocilizumab), for treating adult patients with moderately to severely active rheumatoid arthritis. To view this notice, click here.
